Home > Insider Trading > Filing (0001140361-14-037574)

Filing Details

Accession Number:: 0001140361-14-037574
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-10-08 12:52:21
Reporting Period:: 2014-10-06

Filing Date:: 2014-10-08
Accepted Time:: 2014-10-08 11:52:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1323974	Mwi Veterinary Supply Inc.	MWIV	Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)	020620757

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1334044	Jr N Robert Rebholtz	3041 W. Pasadena Dr. Boise ID 83705		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.01 Per Share	Disposition	2014-10-06	10,181	$146.82	64,819	No	4	S	Indirect	See footnote
Common Stock, Par Value $0.01 Per Share	Disposition	2014-10-06	3,574	$147.56	61,245	No	4	S	Indirect	See footnote
Common Stock, Par Value $0.01 Per Share	Disposition	2014-10-06	1,100	$149.31	60,145	No	4	S	Indirect	See footnote
Common Stock, Par Value $0.01 Per Share	Disposition	2014-10-07	5,387	$142.93	54,758	No	4	S	Indirect	See footnote
Common Stock, Par Value $0.01 Per Share	Disposition	2014-10-07	6,131	$143.73	48,627	No	4	S	Indirect	See footnote
Common Stock, Par Value $0.01 Per Share	Disposition	2014-10-07	1,833	$144.64	46,794	No	4	S	Indirect	See footnote
Common Stock, Par Value $0.01 Per Share	Disposition	2014-10-07	386	$145.50	46,408	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $0.01 Per Share	34,266	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by The Rebholtz Descendants Trust on September 3, 2014.
The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.24 to $147.23, inclusive. Mr. Rebholtz has provided to MWI Veterinary Supply, Inc. (the "Company") and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.235 to $148.09, inclusive. Mr. Rebholtz has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.14 to $149.98, inclusive. Mr. Rebholtz has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.33 to $143.31, inclusive. Mr. Rebholtz has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.34 to $144.31, inclusive. Mr. Rebholtz has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.34 to $145.31, inclusive. Mr. Rebholtz has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.36 to $145.81, inclusive. Mr. Rebholtz has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Held by The Rebholtz Descendants Trust for the benefit of Mr. Rebholtz's family and certain other persons. Mr. Rebholtz expressly disclaims beneficial ownership of any shares held by such trust that exceed his pecuniary interest therein.